Part of the Wall Street Rebel site. Dedicated to delivering institutional quality market analysis, investor education courses, news, and winning buy/sell recommendations - 100% FREE!
Allied Corp. (OTC:ALID) is taking the next step on its road to joining the psilocybin space.
The British Columbia-based company said it signed a letter of intent to buy the psilocybin company
Pacific Sun Fungi.
This move comes as the next logical step in the company’s growth plans, as Allied previously announced it has submitted a provisional patent application for the company’s mushroom formulation focusing on depression and anxiety disorders.
Pacific Sun is known for its
psilocybin-focused research and development activities over the last 10 years, formulating several proprietary technologies and formulations.
Allied Corp. said it was initially created with the goal to develop and secure cannabinoid therapies for veterans and others who suffer from post-traumatic stress disorder.